Abstract
Effect of co-formulated zidovudine, lamivudine and abacavir (Trizivir) on antiretroviral-naive patients presenting with advanced HIV-1 infection.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have